Effect of Dolutegravir on Plasma Glucose Among Human Immunodeficiency Virus Patients in a Community Health Center Setting

Background Dolutegravir has become one of the initial backbones in antiretroviral therapy regimens for most patients with HIV in several recent clinical guidelines. However, dolutegravir has been associated with severe cases of hyperglycemia and the new-onset of diabetes in multiple case reports and...

Descripción completa

Detalles Bibliográficos
Autor principal: Bahamdain, Foud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586418/
https://www.ncbi.nlm.nih.gov/pubmed/36303801
http://dx.doi.org/10.7759/cureus.30556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586418/
https://www.ncbi.nlm.nih.gov/pubmed/36303801
http://dx.doi.org/10.7759/cureus.30556

Ejemplares similares